Compass Therapeutics
CMPX
#7713
Rank
$0.26 B
Marketcap
$1.91
Share price
0.53%
Change (1 day)
30.82%
Change (1 year)

P/S ratio for Compass Therapeutics (CMPX)

P/S ratio as of April 2025 (TTM): 309

According to Compass Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.10. At the end of 2024 the company had a P/S ratio of 236.

P/S ratio history for Compass Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024236
2023N/A
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA